Cibc World Markets Corp Has $7.80 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Cibc World Markets Corp raised its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 35.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,118 shares of the biotechnology company’s stock after purchasing an additional 3,406 shares during the quarter. Cibc World Markets Corp’s holdings in Axon Enterprise were worth $7,796,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the 4th quarter valued at $40,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise during the fourth quarter valued at about $45,000. Prestige Wealth Management Group LLC boosted its holdings in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the last quarter. Stonebridge Financial Group LLC bought a new stake in Axon Enterprise in the 4th quarter worth about $53,000. Finally, GPS Wealth Strategies Group LLC increased its stake in Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after buying an additional 40 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insiders Place Their Bets

In related news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,792 shares of company stock worth $1,087,843 over the last 90 days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Down 2.7 %

AXON opened at $539.99 on Wednesday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a market cap of $41.38 billion, a PE ratio of 139.53, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average of $592.66 and a 200 day moving average of $539.27.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of research analyst reports. Needham & Company LLC restated a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. The Goldman Sachs Group upped their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.